What was the effective date of the absorption-type merger between GENOVA Inc. and GENOVA DESiGN Inc.?

The absorption-type merger between GENOVA Inc. and its subsidiary GENOVA DESiGN Inc. became effective on April 1, 2026, as officially announced by the company.

Why did GENOVA Inc. merge with its wholly-owned subsidiary GENOVA DESiGN Inc.?

GENOVA Inc. merged with GENOVA DESiGN Inc. to strengthen collaboration between its medical platform business and production department, accelerate decision-making, improve service quality, and reduce administrative costs.

What changes occurred at GENOVA Inc. following the completion of the merger on April 1, 2026?

After the merger on April 1, 2026, there were no changes to GENOVA Inc.'s trade name, location, representative, business activities, capital, or fiscal year.

Was any merger consideration paid or new shares issued during the absorption-type merger of GENOVA DESiGN Inc.?

No new shares were issued and no merger consideration was paid by GENOVA Inc. during the absorption-type merger with its wholly-owned subsidiary GENOVA DESiGN Inc.

AI News NQ Analysis

Announcement Regarding the Completion of Absorption-type Merger of Wholly-Owned Subsidiary (GENOVA DESiGN Inc.)

NQ Score 100/100

AI Summary (NQ-processed)

GENOVA Inc. has completed the absorption-type merger of its wholly-owned subsidiary, GENOVA DESiGN Inc. (GD Inc.), effective April 1, 2026. This merger aims to strengthen collaboration between GENOVA's medical platform business and its production department, accelerate decision-making, improve service quality, and enhance corporate value through reduced administrative costs. The merger, being with a 100% owned subsidiary, will not impact consolidated business performance.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of the company that completed the absorption-type merger on April 1, 2026?: A: GENOVA Inc., headquartered in Shibuya-ku, Tokyo, completed the absorption-type merger of its wholly-owned subsidiary GENOVA DESiGN Inc. on April 1, 2026.
Q: What was the effective date of the absorption-type merger between GENOVA Inc. and GENOVA DESiGN Inc.?: A: The absorption-type merger between GENOVA Inc. and its subsidiary GENOVA DESiGN Inc. became effective on April 1, 2026, as officially announced by the company.
Q: Why did GENOVA Inc. merge with its wholly-owned subsidiary GENOVA DESiGN Inc.?: A: GENOVA Inc. merged with GENOVA DESiGN Inc. to strengthen collaboration between its medical platform business and production department, accelerate decision-making, improve service quality, and reduce administrative costs.
Q: What changes occurred at GENOVA Inc. following the completion of the merger on April 1, 2026?: A: After the merger on April 1, 2026, there were no changes to GENOVA Inc.'s trade name, location, representative, business activities, capital, or fiscal year.
Q: Was any merger consideration paid or new shares issued during the absorption-type merger of GENOVA DESiGN Inc.?: A: No new shares were issued and no merger consideration was paid by GENOVA Inc. during the absorption-type merger with its wholly-owned subsidiary GENOVA DESiGN Inc.